SEP 07, 2012
23-Gauge Endoscopic Vitrectomy
By Jeffrey S. Heier, MD
2012 Annual Scientific Meeting of the American Society of Retina Specialists
Retina/Vitreous
Dr. Jeffrey Heier discusses 23-gauge endoscopic vitrectomy and its use in complicated cases and disease states that are otherwise difficult to manage. Beyond its application in patients with retinal detachment, small-gauge endoscopy allows enhanced, atraumatic visualization in cases of compromised anterior segment, severe trauma, congenital disease such as Axenfeld-Rieger syndrome, chronic hypotony, and occluded posterior tube shunt. Dr. Heier presented a retrospective review of 34 cases at the 2012 Annual Scientific Meeting of the American Society of Retina Specialists (ASRS).
Financial Disclosure:
Dr. Heier receives consulting fees or grant support from Acucela, Alcon Laboratories, Alimera, Allergan, Bausch & Lomb, Bayer HealthCare, Endo Optiks, Forsight Labs, Fovea, Genentech, Genzyme, GlaxoSmithKline, Heidelberg Engineering, Ista Pharmaceuticals, Kato Pharmaceuticals, Lpath, NeoVista, Neurotech, Notal Vision, Novartis, Ophthotec, Oraya Therapeutics, Paloma, QLT, Quark Pharmaceuticals, Regeneron, and Sequenom.